{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:23:33Z","timestamp":1767626613995},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T00:00:00Z","timestamp":1217894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s10689-008-9205-9","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T07:05:29Z","timestamp":1217833529000},"page":"15-22","source":"Crossref","is-referenced-by-count":21,"title":["Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry"],"prefix":"10.1007","volume":"8","author":[{"given":"Bifeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Fackenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dezheng","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walmy E.","family":"Sveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffani","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement A.","family":"Adebamowo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temidayo","family":"Ogundiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,5]]},"reference":[{"issue":"3","key":"9205_CR1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/jmg.2004.020446","volume":"42","author":"JD Fackenthal","year":"2005","unstructured":"Fackenthal JD, Sveen L, Gao Q et al (2005) Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet 42(3):276\u2013281. doi: 10.1136\/jmg.2004.020446","journal-title":"J Med Genet"},{"issue":"14","key":"9205_CR2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P et al (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91(14):1241\u20131247. doi: 10.1093\/jnci\/91.14.1241","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"9205_CR3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62(3):676\u2013689. doi: 10.1086\/301749","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"9205_CR4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB et al (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646. doi: 10.1126\/science.1088759","journal-title":"Science"},{"issue":"6","key":"9205_CR5","first-page":"1284","volume":"57","author":"LS Friedman","year":"1995","unstructured":"Friedman LS, Szabo CI, Ostermeyer EA et al (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57(6):1284\u20131297","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9205_CR6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng0596-126","volume":"13","author":"S Neuhausen","year":"1996","unstructured":"Neuhausen S, Gilewski T, Norton L et al (1996) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13(1):126\u2013128. doi: 10.1038\/ng0596-126","journal-title":"Nat Genet"},{"issue":"1\u20133","key":"9205_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/1999\/241046","volume":"15","author":"K Claes","year":"1999","unstructured":"Claes K, Machackova E, De Vos M et al (1999) Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5+3A>G. Dis Markers 15(1\u20133):69\u201373","journal-title":"Dis Markers"},{"issue":"5","key":"9205_CR8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/302099","volume":"63","author":"PN Tonin","year":"1998","unstructured":"Tonin PN, Mes-Masson AM, Futreal PA et al (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63(5):1341\u20131351. doi: 10.1086\/302099","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9205_CR9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/humu.9291","volume":"24","author":"C Hartmann","year":"2004","unstructured":"Hartmann C, John AL, Klaes R et al (2004) Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 24(6):534. doi: 10.1002\/humu.9291","journal-title":"Hum Mutat"},{"issue":"6","key":"9205_CR10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/humu.1136","volume":"17","author":"A Vega","year":"2001","unstructured":"Vega A, Campos B, Bressac-De-Paillerets B et al (2001) The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 17(6):520\u2013521. doi: 10.1002\/humu.1136","journal-title":"Hum Mutat"},{"issue":"10","key":"9205_CR11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.ejhg.5200704","volume":"9","author":"A Bergman","year":"2001","unstructured":"Bergman A, Einbeigi Z, Olofsson U et al (2001) The western Swedish BRCA1 founder mutation 3171ins5; a 37\u00a0cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9(10):787\u2013793. doi: 10.1038\/sj.ejhg.5200704","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"9205_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/humu.9015","volume":"19","author":"US Khoo","year":"2002","unstructured":"Khoo US, Chan KY, Cheung AN et al (2002) Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 19(3):307\u2013308. doi: 10.1002\/humu.9015","journal-title":"Hum Mutat"},{"issue":"10","key":"9205_CR13","first-page":"3144","volume":"7","author":"M Sekine","year":"2001","unstructured":"Sekine M, Nagata H, Tsuji S et al (2001) Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7(10):3144\u20133150","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9205_CR14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/humu.9162","volume":"22","author":"AS Lee","year":"2003","unstructured":"Lee AS, Ho GH, Oh PC et al (2003) Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore. Hum Mutat 22(2):178. doi: 10.1002\/humu.9162","journal-title":"Hum Mutat"},{"issue":"3","key":"9205_CR15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/humu.9049","volume":"20","author":"P Patmasiriwat","year":"2002","unstructured":"Patmasiriwat P, Bhothisuwan K, Sinilnikova OM et al (2002) Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Hum Mutat 20(3):230. doi: 10.1002\/humu.9049","journal-title":"Hum Mutat"},{"issue":"4","key":"9205_CR16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ijc.10194","volume":"98","author":"ML Leon Matsuda De","year":"2002","unstructured":"De Leon Matsuda ML, Liede A, Kwan E et al (2002) BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Int J Cancer 98(4):596\u2013603. doi: 10.1002\/ijc.10194","journal-title":"Int J Cancer"},{"issue":"2","key":"9205_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1086\/302511","volume":"65","author":"HC Mefford","year":"1999","unstructured":"Mefford HC, Baumbach L, Panguluri RC et al (1999) Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet 65(2):575\u2013578. doi: 10.1086\/302511 letter","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9205_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1047-2797(02)00426-X","volume":"13","author":"CA Adebamowo","year":"2003","unstructured":"Adebamowo CA, Ogundiran TO, Adenipekun AA et al (2003) Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol 13(6):455\u2013461. doi: 10.1016\/S1047-2797(02)00426-X","journal-title":"Ann Epidemiol"},{"issue":"2","key":"9205_CR19","first-page":"271","volume":"58","author":"SL Neuhausen","year":"1996","unstructured":"Neuhausen SL, Mazoyer S, Friedman L et al (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58(2):271\u2013280","journal-title":"Am J Hum Genet"},{"issue":"16","key":"9205_CR20","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1158\/0008-5472.CAN-05-0132","volume":"65","author":"ML Freedman","year":"2005","unstructured":"Freedman ML, Penney KL, Stram DO et al (2005) A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res 65(16):7516\u20137522. doi: 10.1158\/0008-5472.CAN-05-0132","journal-title":"Cancer Res"},{"issue":"4","key":"9205_CR21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978\u2013989. doi: 10.1086\/319501","journal-title":"Am J Hum Genet"},{"issue":"5","key":"9205_CR22","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/379378","volume":"73","author":"M Stephens","year":"2003","unstructured":"Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73(5):1162\u20131169. doi: 10.1086\/379378","journal-title":"Am J Hum Genet"},{"issue":"Suppl 1","key":"9205_CR23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cncr.11019","volume":"97","author":"OI Olopade","year":"2003","unstructured":"Olopade OI, Fackenthal JD, Dunston G et\u00a0al (2003) Breast cancer genetics in African Americans. Cancer 97(Suppl 1):236\u2013245. doi: 10.1002\/cncr.11019","journal-title":"Cancer"},{"issue":"1\u20132","key":"9205_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s004399900085","volume":"105","author":"RC Panguluri","year":"1999","unstructured":"Panguluri RC, Brody LC, Modali R, Utley K, Adams-Campbell L, Day AA et al (1999) BRCA1 mutations in African Americans. Hum Genet 105(1\u20132):28\u201331. doi: 10.1007\/s004390051059","journal-title":"Hum Genet"},{"issue":"5","key":"9205_CR25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0959-8049(99)00050-7","volume":"35","author":"A Dorum","year":"1999","unstructured":"Dorum A, Hovig E, Trope C, Inganas M, Moller P et\u00a0al (1999) Three percent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA. Eur J Cancer 35(5):779\u2013781","journal-title":"Eur J Cancer"},{"issue":"1","key":"9205_CR26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","volume":"13","author":"FJ Couch","year":"1996","unstructured":"Couch FJ, Farid LM, DeShano ML et al (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13(1):123\u2013125. doi: 10.1038\/ng0596-123","journal-title":"Nat Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-008-9205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-008-9205-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-008-9205-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:45:58Z","timestamp":1559238358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-008-9205-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["9205"],"URL":"https:\/\/doi.org\/10.1007\/s10689-008-9205-9","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,5]]}}}